Skip to main content
Top

Endocrine Pathology

Issue 4/2007

Content (8 Articles)

Dr. Kalman T. Kovacs

Vânia Nosé, Bernd W Scheithauer

Immunohistochemical Detection of Somatostatin Receptor (SSTR) Subtypes 2A and 5 in Pituitary Adenoma from Acromegalic Patients: Good Correlation with Preoperative Response to Octreotide

Mao Takei, Masanori Suzuki, Hanako Kajiya, Yudo Ishii, Shigeyuki Tahara, Takashi Miyakoshi, Noboru Egashira, Susumu Takekoshi, Naoko Sanno, Akira Teramoto, Robert Yoshiyuki Osamura

P53 Gene Mutations in Pituitary Carcinomas

Yoshinori Tanizaki, Long Jin, Bernd W. Scheithauer, Kalman Kovacs, Federico Roncaroli, Ricard V. Lloyd

Basic Research

Characterization of the Functional and Growth Properties of Cell Lines Established from Ileal and Rectal Carcinoid Tumors

Gail A. Stilling, Heyu Zhang, Katharina H. Ruebel, Alexey A. Leontovich, Long Jin, Yoshinori Tanizaki, Shuya Zhang, Lori A. Erickson, Timothy Hobday, Ricardo V. Lloyd

Sclerosing Epithelioid Fibrosarcoma of the Pituitary

Anamaria Massier, Bernd W. Scheithauer, Harris C. Taylor, Christopher Clark, Luis Llerena

Case

Leiomyoma of the Adrenal Gland Presenting as a Non-Functioning Adrenal Incidentaloma: Case Report and Review of the Literature

Jingmei Lin, Matthew J. Wasco, Melvin Korobkin, Gerard Doherty, Thomas J. Giordano

10th International Pituitary Pathology Meeting Abstracts

Tenth Meeting of the International Pituitary Club (Abstracts)

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine